More questions than answers for Guidant and Medtronic in drug-coated stents race, say analysts
This article was originally published in Clinica
Executive Summary
Morgan Stanley Dean Witter says that it came away from a trip through Europe recently with "a sense of nervousness" over the position of Guidant and Medtronic in the race to provide an effective drug delivery stent.